[go: up one dir, main page]

AU7717500A - Anti-hypercholesterolemic drug combination - Google Patents

Anti-hypercholesterolemic drug combination

Info

Publication number
AU7717500A
AU7717500A AU77175/00A AU7717500A AU7717500A AU 7717500 A AU7717500 A AU 7717500A AU 77175/00 A AU77175/00 A AU 77175/00A AU 7717500 A AU7717500 A AU 7717500A AU 7717500 A AU7717500 A AU 7717500A
Authority
AU
Australia
Prior art keywords
drug combination
hypercholesterolemic
hypercholesterolemic drug
combination
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77175/00A
Inventor
Yu-Sheng Chao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU7717500A publication Critical patent/AU7717500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU77175/00A 1999-09-30 2000-09-26 Anti-hypercholesterolemic drug combination Abandoned AU7717500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15718499P 1999-09-30 1999-09-30
US60157184 1999-09-30
PCT/US2000/026414 WO2001022962A1 (en) 1999-09-30 2000-09-26 Anti-hypercholesterolemic drug combination

Publications (1)

Publication Number Publication Date
AU7717500A true AU7717500A (en) 2001-04-30

Family

ID=22562671

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77175/00A Abandoned AU7717500A (en) 1999-09-30 2000-09-26 Anti-hypercholesterolemic drug combination

Country Status (2)

Country Link
AU (1) AU7717500A (en)
WO (1) WO2001022962A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL362244A1 (en) * 2000-09-01 2004-10-18 Sankyo Company, Limited Medicinal compositions
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
SI1355644T1 (en) 2001-01-26 2006-10-31 Schering Corp The use of substituted azetidinone compounds for the treatment of sitosterolemia
IL156445A0 (en) 2001-01-26 2004-01-04 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
DK1429756T3 (en) 2001-09-21 2007-03-19 Schering Corp Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
CA2478184A1 (en) * 2002-03-12 2003-09-25 Merck & Co., Inc. Drug combination therapy
GB0218781D0 (en) 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
US20040092499A1 (en) 2002-11-06 2004-05-13 Schering Corporation Methods and therapeutic combinations for the treatment of autoimmune disorders
ATE418551T1 (en) 2003-03-07 2009-01-15 Schering Corp SUBSTITUTED AZETIDINONE DERIVATIVES, THEIR PHARMACEUTICAL FORMULATIONS AND THEIR USE IN THE TREATMENT OF HYPERCHOLESTEROLEMIA
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
CN1756755A (en) 2003-03-07 2006-04-05 先灵公司 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
WO2004081002A1 (en) 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
RU2358734C2 (en) 2003-08-29 2009-06-20 Кова Ко., Лтд. High-lipid plaque stabilisation method and method of destruction prevention
UY28501A1 (en) 2003-09-10 2005-04-29 Astrazeneca Uk Ltd CHEMICAL COMPOUNDS
GB0324791D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
GB0406757D0 (en) * 2004-03-26 2004-04-28 Avecia Ltd Process and compounds
TW200619204A (en) * 2004-12-10 2006-06-16 Kowa Co Method for reduction, stabilization and prevention of rupture of lipid rich plaque
CN102885797A (en) * 2012-10-29 2013-01-23 福州海王福药制药有限公司 Composition containing pravastatin calcium as well as preparation method and application thereof
IT201700025666A1 (en) * 2017-03-08 2018-09-08 Neilos S R L Composition for use in the treatment of hypercholesterolemia and in the prevention of cardiovascular diseases.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69636783T2 (en) * 1995-11-02 2007-10-18 Warner-Lambert Co. Llc METHOD AND PHARMACEUTICAL COMPOSITION FOR REGULATING LIPID CONCENTRATION

Also Published As

Publication number Publication date
WO2001022962A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
AU2001288294A1 (en) Anti-hypercholesterolemic drug combination
AU5259100A (en) Medicament
AU1071301A (en) Pharmaceutical compounds
AU7717500A (en) Anti-hypercholesterolemic drug combination
AU2672501A (en) Medicament dispenser
AU2509901A (en) Medicament dispenser
AU6314900A (en) Biarylurea derivatives
AU6714700A (en) Cyclopropylindole derivatives
AU2955200A (en) Cannula
AU2001269529A1 (en) Medicine comprising dicyanopyridine derivative
AU2919001A (en) Syringe
AU1514401A (en) Medicament dispenser
AU3837300A (en) Remedies
AU1887401A (en) Medicinal composition
AU7952800A (en) 2-alkoxybenzene derivatives
AU2002221099A1 (en) Combination drugs
AU2991200A (en) Antiangiogenic drugs
AU1645700A (en) Oenothein medicaments
AU5722900A (en) Pharmaceutical compounds
AU1541601A (en) Syringes
AU2001232244A1 (en) Drug comprising combination
AU6262300A (en) Indolinylamide derivatives
AU1558300A (en) 1-cycloalkylpyrazoyl-benzoyl derivatives
AU4726299A (en) Drug dispenser
AU3133400A (en) Syringe

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase